Clover Health Investments Management
Management criteria checks 2/4
Clover Health Investments' CEO is Andrew Toy, appointed in Jan 2023, has a tenure of 1.33 years. total yearly compensation is $10.15M, comprised of 6.9% salary and 93.1% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth €1.97M. The average tenure of the management team and the board of directors is 1.8 years and 3.3 years respectively.
Key information
Andrew Toy
Chief executive officer
US$10.2m
Total compensation
| CEO salary percentage | 6.9% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.5% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$157m |
| Dec 31 2023 | US$10m | US$700k | -US$213m |
| Sep 30 2023 | n/a | n/a | -US$226m |
| Jun 30 2023 | n/a | n/a | -US$260m |
| Mar 31 2023 | n/a | n/a | -US$336m |
| Dec 31 2022 | US$10m | US$500k | -US$340m |
| Sep 30 2022 | n/a | n/a | -US$443m |
| Jun 30 2022 | n/a | n/a | -US$402m |
| Mar 31 2022 | n/a | n/a | -US$615m |
| Dec 31 2021 | US$142m | US$450k | -US$588m |
| Sep 30 2021 | n/a | n/a | -US$527m |
| Jun 30 2021 | n/a | n/a | -US$487m |
| Mar 31 2021 | n/a | n/a | -US$160m |
| Dec 31 2020 | US$9m | US$415k | -US$136m |
| Sep 30 2020 | n/a | n/a | -US$89m |
| Jun 30 2020 | n/a | n/a | -US$145m |
| Mar 31 2020 | n/a | n/a | -US$272m |
| Dec 31 2019 | US$424k | US$400k | -US$364m |
Compensation vs Market: Andrew's total compensation ($USD10.15M) is above average for companies of similar size in the German market ($USD1.06M).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew Toy (44 yo)
1.3yrs
Tenure
US$10,154,701
Compensation
Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 9.8yrs | no data | 17.91% $ 76.3m | |
| Co-Founder | 1.3yrs | US$10.15m | 0.46% $ 2.0m | |
| General Counsel | less than a year | US$1.47m | 0.028% $ 118.1k | |
| Chief Executive Officer of Home Care | 1.8yrs | US$1.35m | 0.10% $ 433.9k | |
| Chief Executive Officer of Medicare Advantage | 1.3yrs | US$2.49m | 0.13% $ 564.5k | |
| Interim CFO | less than a year | no data | no data | |
| Chief Technology Officer | 2.3yrs | no data | 0.59% $ 2.5m | |
| Head of Investor Relations & Corporate strategy | no data | no data | no data | |
| Chief Compliance Officer | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Chief Medical Officer of Clover Assistant | 2.5yrs | no data | no data | |
| Chief Medical Officer | 3.3yrs | no data | no data |
1.8yrs
Average Tenure
45yo
Average Age
Experienced Management: 7QD's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 9.8yrs | no data | 17.91% $ 76.3m | |
| Co-Founder | 5.5yrs | US$10.15m | 0.46% $ 2.0m | |
| Independent Director | 3.3yrs | US$280.93k | 0.067% $ 284.7k | |
| Independent Director | 7.3yrs | US$246.55k | 0.068% $ 288.2k | |
| Board Observer | no data | no data | no data | |
| Independent Director | 3.2yrs | US$268.43k | 0.051% $ 216.0k | |
| Independent Director | 1.8yrs | US$250.30k | 0.042% $ 177.0k | |
| Independent Director | 1.5yrs | US$247.80k | 0.072% $ 308.4k | |
| Lead Independent Director | 3.1yrs | US$320.16k | 0.045% $ 191.2k |
3.3yrs
Average Tenure
47yo
Average Age
Experienced Board: 7QD's board of directors are considered experienced (3.3 years average tenure).